Quick Answer
AbbVie Inc. reported Total Revenue of $61.16 billion for the year ending 2025.
- AbbVie Inc. showed an increase of +8.6% in Total Revenue from 2024 to 2025.
- This data is from AbbVie Inc.'s annual report (Form 10-K), filed with the SEC on February 20, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2014: $4.93 billion | Q3 2014: $5.02 billion | Q1 2015: $5.04 billion | Q2 2015: $5.48 billion | Q3 2015: $5.94 billion | Q1 2016: $5.96 billion | Q2 2016: $6.45 billion | Q3 2016: $6.43 billion | Q1 2017: $6.54 billion | Q2 2017: $6.94 billion | Q3 2017: $7.00 billion | Q4 2017: $7.74 billion | Q1 2018: $7.93 billion | Q2 2018: $8.28 billion | Q3 2018: $8.24 billion | Q4 2018: $8.31 billion | Q1 2019: $7.83 billion | Q2 2019: $8.26 billion | Q3 2019: $8.48 billion | Q4 2019: $8.70 billion | Q1 2020: $8.62 billion | Q2 2020: $10.43 billion | Q3 2020: $12.90 billion | Q4 2020: $13.86 billion | Q1 2021: $13.01 billion | Q2 2021: $13.96 billion | Q3 2021: $14.34 billion | Q4 2021: $14.89 billion | Q1 2022: $13.54 billion | Q2 2022: $14.58 billion | Q3 2022: $14.81 billion | Q4 2022: $15.12 billion | Q1 2023: $12.23 billion | Q2 2023: $13.87 billion | Q3 2023: $13.93 billion | Q4 2023: $14.30 billion | Q1 2024: $12.31 billion | Q2 2024: $14.46 billion | Q3 2024: $14.46 billion | Q4 2024: $15.10 billion | Q1 2025: $13.34 billion | Q2 2025: $15.42 billion | Q3 2025: $15.78 billion | Q4 2025: $16.62 billion.
- Over the full 10 years of available data (2016 to 2025), AbbVie Inc.'s Total Revenue has grown by 138.6%.
- Historical annual values: Fiscal year 2025: $61.16 billion | Fiscal year 2024: $56.33 billion | Fiscal year 2023: $54.32 billion | Fiscal year 2022: $58.05 billion | Fiscal year 2021: $56.20 billion | Fiscal year 2020: $45.80 billion | Fiscal year 2019: $33.27 billion | Fiscal year 2018: $32.75 billion | Fiscal year 2017: $28.22 billion | Fiscal year 2016: $25.64 billion.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: